The government of China has pledged to supply any vaccine that they manage to develop against COVID19 to African first free of charge.
China is leading the race to develop a COVID19 vaccine and its scientists are largely pinning their hopes on a technology that has been used for decades.
In recent weeks, China had issued statements that they had seen the significant success of tests among animals while another group was sighting success in human trials.
As of now, five out of 10 potential vaccines undergoing clinical trials have been developed by Chinese scientists, while a sixth is the result of a partnership between a Chinese company and a German biotech firm, according to the World Health Organisation
“We gathered here with our new and old friends through video to discuss anti-epidemic cooperation and cement China-Africa brotherhood,” said Xi in a speech on Wednesday aired on state media.
China to Fulfill its Pledge on Helping Africa to fight COVID19
“We are making good on our promises at the earlier Beijing summit with concrete efforts, as well as contributing to the global anti-epidemic cooperation. We believe that humans will defeat the epidemic ultimately, and Chinese and African people will definitely live a better life,” Xi said.
Xi added China would push the Group of 20 to slow down debt repayment for African nations and that China’s construction of a new Africa Center of Disease Control headquarters would start “ahead of schedule” this year, despite the pandemic.
State media reported China has sent 30 million testing kits, 10,000 ventilators 80 million masks monthly to Africa, in addition to teams of experts to help nations fight the coronavirus.
So far, Africa has registered of 267,818 cases, 7,219 deaths from COVID19 123,054 recoveries. Africa according to stats has been managing the pandemic quite well and the promise of receiving the vaccine from China will be a welcome gesture.
Author: Moses Echodu
Moses is an avid Sports and Tech enthusiast. He loves to keep up to date with all the latest information and research on some of the most compelling stories.